Objectives: This study focuses on the mechanism of interaction of sitamaquine with Leishmania donovani membranes, and its accumulation within the parasites.
Introduction
Leishmania donovani is the agent of anthroponotic human visceral leishmaniasis, which occurs mainly in India, Sudan and Bangladesh. This disease is fatal in the absence of treatment and some recent improvements in antileishmanial chemotherapy have proved to be efficient and promising. 1 Among these new treatments, sitamaquine (WR-6026, SB-252220), an 8-aminoquinoline analogue, is being developed by GlaxoSmithKline (GSK) 2 -4 ( Figure 1 ) and Phase II trials in India and Kenya have yielded encouraging results. 5 Some complementary toxicological data are presently being developed explaining its delayed marketing. Like miltefosine, sitamaquine has the advantage of being effective by the oral route; 5 however, it was not active by the topical route for the treatment of cutaneous leishmaniasis. 6 Thus, sitamaquine could be promising as an oral therapy for the treatment of visceral leishmaniasis and it is important to understand its mechanism of action. Therefore, the action of sitamaquine was investigated on L. donovani promastigotes at the late log phase of growth/beginning of stationary phase, the axenic amastigotes of our L. donovani clone giving unstable cultures. In a previous paper, we reported that the action of sitamaquine on L. donovani promastigotes was diminished when the amount of protein in the medium was increased, suggesting interactions between sitamaquine and proteins. 7 Thus, serum proteins could act as a reservoir of sitamaquine.
# The Author 2010. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org J Antimicrob Chemother 2010; 65: 2548 -2555 doi:10.1093/jac/dkq371 Advance Access publication 18 October 2010 In order to understand the interaction of antileishmanial drugs with the plasma membrane of Leishmania, we performed a lipidomic analysis of L. donovani promastigote membranes to identify the major lipids in the membrane composition. 8 Subsequently, we described the biophysical interactions of sitamaquine with the major lipids from L. donovani promastigote plasma membrane using a monolayer of each lipid in a Langmuir trough. 7 We found that sitamaquine interacted with anionic phospholipids such as phosphatidylinositol (PI) or phosphatidylglycerol (PG), while no interaction was found with zwitterionic phospholipids and sterols. 7 After the initial interaction of sitamaquine with the monolayer, hydrophobic interactions between aromatic rings of sitamaquine and acyl chains of monolayer phospholipids allowed it to insert completely. In the present paper, we examined the interaction of sitamaquine with a biomimetic monolayer made up of a mixture of lipids whose composition is close to that of an L. donovani plasma membrane. We also studied the kinetics of sitamaquine accumulation within and efflux from L. donovani promastigotes and the effect on lipid trafficking.
Materials and methods

Chemical compounds
Sitamaquine was kindly supplied by GSK Laboratories (London, UK). Cholesterol oxidase (CH-OX) from Escherichia coli, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), 1-palmitoyl-2-oleoyl-snglycero-3-phosphatidylethanolamine (POPE), 1,2-distearyl-sn-glycero-3-phosphatidylcholine (DSPC), 1,2-dipalmitoyl-sn-glycero-3-phosphatidylglycerol (DPPG) and ergosterol (99% pure) were purchased from Sigma (Saint-Quentin Fallavier, France). The lipids were dissolved in a chloroform/ethanol 4/1 (v/v) mixture at a concentration of 10 -3 M.
Parasite strains and culture
Promastigote forms of the wild-type (WT) L. donovani LV9 (MHOM/ET/67/ HU3) line were grown in M-199 medium (Sigma, Saint-Quentin Fallavier, France) supplemented with 10% inactivated fetal calf serum (Invitrogen, Eragnie, France), 40 mM HEPES (VWR, Paisley, Scotland), 100 mM adenosine (Sigma, Saint-Quentin Fallavier, France) and 0.5 mg/L haemin (Sigma, Saint-Quentin Fallavier, France) in the presence of 50 mg/mL gentamicin at 268C in 5% CO 2 .
Composition of the biomimetic monolayer
The choice of components of the biomimetic monolayer was determined according to results obtained from previous studies on L. donovani plasma membrane composition. 8, 9 Thus, the biomimetic monolayer composition was: ergosterol 30%, POPE 29%, DSPC 27%, and DPPG 14%, as previously described in Saint-Pierre-Chazalet et al. 10 This composition reflected the balance between the polar head groups of phospholipids, the proportion of their unsaturated acyl chains and the neutral lipids found from the lipidomic analysis.
Isotherms of the biomimetic monolayer
Monolayers were prepared using a Teflon trough (6.2×26.3×0.5 cm) provided by Riegler and Kirstein (Wiesbaden, Germany) filled with Millipore w water (MV¼18, pH 5.6) as described previously. 11 The lipid monolayers were obtained by spreading 20 mL of a 10 23 M organic solution of each lipid at the air -water interface. The film was compressed a few minutes after the evaporation of the solvent, and the compression isotherms (P/A) were recorded.
The surface pressure (P) was measured using the Wilhelmy method, by means of a filter paper plate. The mean molecular area A was determined as A¼S/N where S is the surface of the trough and N is the number of molecules spread. An electronic device enabled us to keep the surface pressure constant by monitoring the displacement of the barriers. The speed of movement of the barriers (3×10 22 cm s 21 ) was kept constant during the experiments. All experiments were performed at 21+18C. The monolayer of phospholipids was compressed up to 6 or 30 mN/m: the surface pressure of a biological membrane. 12 The pressure was kept constant while an aqueous solution of 10 23 M sitamaquine was injected with a microsyringe under the monolayer at a final concentration of 1.6×10 25 M. 7 If an interaction occurred between these molecules and the monolayer, the barriers were moved back to keep a constant pressure (6 or 30 mN/m), and the variation in the mean molecular area (DA) of the lipid was recorded as a function of time over 60 min (adsorption kinetics). The molecules remaining at the interface (lipids and any sitamaquine that had adsorbed and/or penetrated) were compressed and a new P/A isotherm was recorded. If an interaction (penetration and/or adsorption) of the drug with the monolayer had taken place, this isotherm was shifted to higher areas compared with the initial pure lipid monolayer.
Sterol depletion
For sterol depletion, L. donovani promastigotes were cultured in flasks at an initial density of 10 6 promastigotes/mL in 100 mL of the medium described above. The flasks were placed in an orbital incubator under continuous shaking (150 rpm) at 268C. At the end of logarithmic phase, WT promastigotes entering the stationary phase ( 10 8 parasites/mL) were harvested by centrifugation (4000 g, 48C, 10 min) and washed three times with large volumes of serum-free medium (SFM) to eliminate all traces of sterol in the medium that would reduce the efficiency of sterol depletion. The pellet was then suspended in 6 mL SFM and this suspension was then divided into two equal parts: one control sample and one sample incubated with CH-OX for 2 h at 268C. After this period of sterol depletion, parasites were washed in PBS pH 7.2 to eliminate CH-OX. The pellet was suspended in SFM and the cell density was adjusted to 4×10 8 parasites/mL prior to determining their drug susceptibility.
Determination of cholesterol content
Depleted parasites and controls were washed in 1×PBS (Sigma, SaintQuentin Fallavier, France), centrifuged (4000 g, 48C, 10 min) and the pellet was lysed in 50 mM Tris-HCl/5 mM EDTA, pH 7.4 buffer to disrupt the parasites. Parasite disruption was completed by treating the suspension with ultrasound for six cycles of 30 s each at 08C. Sterols were assayed using the colorimetric cholesterol quantification kit (CliniSciences, Montrouge, France) based on the cholesterol esterase/cholesterol oxidase combined system and performed on a C6000 Roche/Hitachi analyser (Paris, France). We checked the specificity of the assay using pure Sitamaquine interaction with Leishmania 2549 JAC compounds and found that this system quantified all sterols, not only cholesterol but also ergosterol, present in L. donovani (data not shown).
Susceptibility of parasites to sitamaquine
Susceptibility to sitamaquine was determined in flat-bottomed 96-well plastic tissue-culture plates maintained at 268C in an atmosphere of 5% CO 2 . Each well of the plates was filled with 100 mL of the steroldepleted or control parasite suspension adjusted to 4×10 8 cells/mL, and plates were incubated at 278C for 1 h before drug addition. Sitamaquine solutions were added so as to attain the final desired concentrations (200 and 100 mM) with each concentration in triplicate. After a 1 h incubation period at 278C in the dark and under a 5% CO 2 atmosphere, the viability of promastigotes was assessed using the tetrazolium dye MTT colorimetric method as previously described. 10 Leishmania treatment and cell fractionation L. donovani promastigotes were cultured in Erlenmeyer flasks at an initial density of 10 6 promastigotes/mL in 1 L of the medium defined above. Flasks were placed in an orbital incubator under continuous shaking (150 rpm) at 268C. At the end of the logarithmic phase, treatment with sitamaquine (50 mM) was carried out at 48C and 268C. Cells were incubated with sitamaquine for 30 min, 1, 3, 6, 15 and 24 h and, for each incubation time, a 100 mL volume of the sitamaquine-treated promastigote suspension containing 10 10 parasites was withdrawn. Parasites were harvested by centrifugation at 4000 g at 48C for 10 min and washed three times with large volumes of cold Tris-buffered saline (TBS; 10 mM Tris-HCl, 145 mM NaCl, pH 7). The supernatant was discarded and the pellet was kept at 2808C. The pellet was then thawed and cell lysis was performed in acidic water (pH 3.3: 115 mM acetic acid/6.45 mM ammonium) by three cycles of freezing (21708C) and thawing (378C). Parasite breakage was assessed by phase-contrast microscopy. The lysate was centrifuged at 150000 g, 60 min, 48C (Beckman Optimun TM LE 80K). The supernatant was deproteinized using acetonitrile (1 :1, v/v). After a 20000 g centrifugation at 48C for 60 min, the supernatant was considered as the cytosolic fraction for mass spectrometry-electrospray ionization (MS-ESI) analysis. A 3 mL volume of mobile phase composed of methanol/acidic water (57/43) was added to the pellet and the mixture was vortexed and sonicated. After centrifugation at 4000 g for 10 min, the supernatant was filtered on a 0.42 mm membrane. The filtrate was considered as the total membrane fraction.
Quantification of sitamaquine
Sitamaquine was assayed using a new HPLC method coupled with tandem mass spectrometry. The HPLC system consisted of a Dionex Ultimate 3000 pump equipped with a Dionex WPS-3000PL autosampler automatic injector. The samples were maintained at 108C in the autosampler and the column was placed in an oven at 258C.
Liquid chromatography was performed in isocratic mode with an Uptisphere ODSB (INTERCHIM) C18 250×2.1 mm with particle size of 5 mm column. The mobile phase was composed of methanol/buffer 57/43. The buffer solution consisted of 115 mM acetic acid and 6.45 mM ammoniac mixture with pH adjusted to 3.3. The flow rate was fixed at 0.3 mL/min; volumes of 10 mL were injected. Sitamaquine eluted at 11.1 min; the total run time was set at 18 min.
The mass spectrometer used was a Waters-Micromass Quattro Ultima (Saint-Quentin-en-Yvelines, France) with electrospray interface and a triple quadrupole analyser. Data acquisition and analysis were performed using Masslynx 3.5 software. The mass spectrometer was interfaced with the HPLC system using an ESI electrospray ion source. A remote valve was programmed to send the first 4 min of the chromatography to waste in order to avoid salt accumulation in the ESI capillary. The capillary voltage was set to 4000 V and the cone voltage to 100 V; the source temperature was set to 1208C; the desolvation gas (N 2 ) was set at a flow of 540 L/h and a temperature of 3508C. The positive ion mode full-scan spectra of the sitamaquine dissolved in the elution mobile phase showed an intense signal for the protonated molecular ion and m/z 344. 4 Sitamaquine accumulation during energy depletion L. donovani promastigotes were pre-incubated in pH 6.8 PBS with glucose (1 g/L) or without glucose in the presence of 5 mM 2-deoxy-D-glucose and 10 mM azide for 30 min at 268C, after which all parasites were treated with sitamaquine at a final concentration of 50 mM for 1 h at 268C. Sitamaquine was then assayed according to the method described above.
Sitamaquine efflux
Parasites were treated with 50 mM sitamaquine for 1 h at 268C, then incubated in a sitamaquine-free medium for 1, 3 and 5 h. Sitamaquine was assayed according to the method described above.
Sitamaquine efflux during energy depletion L. donovani promastigotes were treated with 50 mM sitamaquine for 1 h and after centrifugation, they were washed and re-incubated in pH 6.8 PBS sitamaquine-free medium with glucose (1 g/L) or without glucose in the presence of 5 mM 2-deoxy-D-glucose and 10 mM azide for 1, 3 and 5 h at 268C.
NMR proton spectroscopy
NMR proton analysis was carried out as previously described. 10 
Statistical analysis
The statistical significance was analysed using a Kruskal-Wallis test for non-parametric data and a Student's t-test for parametric data. A threshold of P,0.05 was considered statistically significant.
Results
We found in a previous study investigating the interaction of sitamaquine with monolayers constituted of each molecular species of lipid used separately that sitamaquine had an affinity for anionic phospholipids. 7 In the present work, we aimed to confirm this observation on a lipid monolayer imitating the plasma membrane of L. donovani promastigotes.
Lipid composition of the biomimetic monolayer
The composition of the biomimetic monolayer was determined according to previous lipidomic studies performed in Leishmania membranes: 8, 9 ergosterol, 30%; POPE, 29%; DSPC, 27%; and DPPG, 14%. This simple composition was designed to reflect Coimbra et al.
the balance between the polar head groups of the phospholipids, the proportion of unsaturated acyl chains and the relative percentage of neutral lipids found from these lipidomic analyses.
Isotherm of the biomimetic monolayer
The isotherm of the biomimetic monolayer in Figure 2 shows that the monolayer is in a liquid-expanded phase. Taking into account the mean molecular areas obtained from the isotherms of pure lipids at different pressures, 6, 15, 30 and 40 mN/m, 7 the mean molecular area (A c ¼ 30%A ergo + 29%A POPE + 27%A DSPC + 14% A DPPG ) was calculated at these different surface pressures (Table 1) . These values are compared with the mean molecular area of the biomimetic membrane A biom recorded in Figure 2 . At 6 mN/m, the measured mean molecular area of the biomimetic monolayer (A biom ) was higher than the calculated mean molecular area (A c ), indicating a repulsion between the lipids involved due to a non-homogeneous distribution of the lipid at the air-water interface. However, after compression, at 30 mN/m, the mean molecular area was the same in both cases (A c ¼ A biom ¼ 46.2 Å 2 /molecule). Usually, this result would suggest that no interaction occurred between the components. However, at high pressure a weak repulsion could occur, but be compensated by the energy input. Indeed, the isotherm of the biomimetic monolayer was in the liquid-expanded phase, corresponding to a fluid phase with the presence of condensed domains, as expected in a biological membrane.
Interaction of sitamaquine with the biomimetic membrane
Sitamaquine was injected under the biomimetic monolayer at two constant surface pressures: 6 and 30 mN/m, following the protocol described in the Materials and methods section. After 1 h, it was observed that the mean molecular area of the biomimetic monolayer increased (DA variation) by 10 Å 2 /molecule at 6 mN/m and 3 Å 2 /molecule at 30 mN/m. New isotherms were then recorded (Figure 2 ). From our previous results, 7 we observed that sitamaquine only interacted with anionic phospholipids, and the DA variation obtained after injection of sitamaquine at 30 mN/m, in the presence of a monolayer of pure anionic DPPG was 21 Å 2 /molecule. It is noteworthy that, in the present work, at 30 mN/m (a pressure close to that of the biological membrane), the DA variation (3 Å 2 /molecule) corresponded exactly to the value obtained in the presence of the monolayer of the anionic DPPG alone. Since the biomimetic monolayer was composed of 14% DPPG, if only DPPG was involved in the interaction, the variation of DA would be 21×0.14 ¼ 2.94 Å 2 /molecule. This value is very close to the one that we obtained with the biomimetic monolayer (3 Å 2 /molecule), confirming that only the anionic phospholipids were involved in the interaction of sitamaquine with membrane phospholipids. At low pressure (6 mN/m), the DA variation was higher (10 Å 2 /molecule) because the monolayer was more fluid and more quinoline rings of sitamaquine could insert between the phospholipid acyl chains. These results are in agreement with those obtained in our previous study. 7 In a first step, sitamaquine was adsorbed beneath the biomimetic monolayer, by electrostatic interaction, then the quinoline rings insert between the hydrophobic chains of the phospholipids.
Susceptibility of L. donovani promastigotes to sitamaquine after sterol depletion
The interaction of sitamaquine with the parasite membrane is a prerequisite for its action. Recently, we described the role of lipid rafts in the action of miltefosine. 10 Therefore, in the present study, we investigated their role in the action of sitamaquine. Although we previously observed that there was no direct interaction between sterols and sitamaquine, 7 it was important to validate the data obtained on an artificial monolayer using live L. donovani promastigotes.
Therefore, we depleted parasites of sterols using the enzyme CH-OX, which catalyses specific oxidation of raft cholesterol to cholestenone, which is ejected from lipid rafts. The conditions of sterol depletion (1 U of CH-OX/mL of medium containing 10 8 parasites) had been previously optimized to maintain parasite viability. 10 The viability of the cholesterol-depleted parasites was Sitamaquine interaction with Leishmania 2551 JAC checked before incubating them with sitamaquine. The degree of sterol depletion was evaluated by assaying the sterol content of depleted parasites compared with untreated ones. The sterol depletion provoked by CH-OX had no significant effect on parasite viability, since the mitochondrial activity was reduced by only 20% (data not shown). We then measured drug susceptibility to sitamaquine in sterol-depleted parasites, which were incubated in the presence of high concentrations of sitamaquine (100 and 200 mM) at a high cell density for a short (1 h) period before an MTT assay. These particular conditions of cell density, sitamaquine concentration and incubation times were used because, in the absence of sterols, the parasites could not grow and it is not possible to measure the activity over a 72 h incubation period, as in the classic assay. Therefore, we chose sitamaquine concentrations higher than the IC 50 value at 72 h. Sterol depletion using CH-OX did not significantly modify parasite susceptibility to sitamaquine (Figure 3) . These results confirm the absence of interaction of sitamaquine with sterols as observed previously.
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Sitamaquine uptake
When incubated with 50 mM sitamaquine, the cells rapidly accumulated the drug within the first 30 min and the concentration remained at a plateau for between 1 and 24 h. The sitamaquine concentrations were .10-fold higher in the cytosol than in membranes ( Figure 4 ). We did not observe a significant difference in sitamaquine accumulation between 48C and 268C (data not shown).
Sitamaquine uptake during energy depletion
In order to assess whether the sitamaquine entry required an energy-dependent transporter, sitamaquine accumulation was measured under conditions of energy depletion. This resulted in an increase in sitamaquine accumulation of 3.5-fold compared with the control ( Figure 5 ). This observation suggests not only that sitamaquine uptake is not energy dependent but also that an energy-dependent sitamaquine efflux could occur.
Sitamaquine efflux
In order to test this hypothesis, we analysed the sitamaquine efflux in conditions of energy depletion. When re-incubated in a sitamaquine-free medium, and in the presence of glucose, sitamaquine was rapidly lost from the treated promastigotes, since after 1 h of re-incubation, .95% of the accumulated sitamaquine had left the cells (Figure 6 ). On the other hand, in the absence of glucose, the sitamaquine efflux was estimated at ,25% after a 5 h incubation period (Figure 6 ), suggesting that sitamaquine efflux occurred by an energy-dependent process.
Lipid trafficking
Since sitamaquine is a molecule containing a hydrophobic quinoline ring, with an affinity for anionic phospholipids, we assessed whether sitamaquine was able to modulate lipid trafficking from internal compartments to the plasma membrane. When lipid trafficking is modified by a drug or a physiological event, the lipids detected by NMR spectroscopy on whole cells may be modified. In the present case, sitamaquine at 150 mM did not seem to change the intensity of the lipid signals in the spectra (data not shown). Comparison of the peak areas confirmed that there was no significant difference between untreated and sitamaquine-treated parasites.
Discussion
Sitamaquine, an 8-aminoquinoline, is in development for the treatment of visceral leishmaniasis by the oral route by GSK Laboratories. 5 Toxicological data are being collected from clinical studies before this drug can be marketed. The promising results obtained from clinical studies in India and Africa justify studying WT with CH-OX Figure 3 . Determination of the susceptibility to sitamaquine of L. donovani wild-type (WT) promastigotes after sterol depletion using cholesterol oxidase (CH-OX) (n¼3). Sterol depletion consisted of pre-incubation of parasites (10 8 parasites/mL) with 1 U/mL CH-OX for a 2 h period. After washing, parasites were incubated with sitamaquine for 1 h and their susceptibility to sitamaquine was assessed by the MTT assay. The optical density values for 100% mitochondrial activity ranged from 0.800 to 0.950. WT with CH-OX versus WT without CH-OX at 100 and 200 mM: not significant (P. 0.05). Coimbra et al.
the mechanism of action of this interesting compound. When describing the interaction of sitamaquine with lipid monolayers, we found both a specific affinity towards anionic phospholipids such as PI and PG and a hydrophobic interaction with the acyl chains of phospholipids allowing integration of sitamaquine into the external layer of the plasma membrane. 7 In this article, this interaction was confirmed using a biomimetic model mimicking the L. donovani plasma membrane. However, the data show that only a few sitamaquine molecules were inserted into the biomimetic monolayer at the cohesion pressure of biological membranes (DA ¼ 3 Å 2 /molecule at 30 mN/m), suggesting that a small quantity of sitamaquine can be inserted within the plasma membrane of parasites. The amounts of sitamaquine in Leishmania membrane fractions (Figures 4 and 5) were negligible, suggesting that sitamaquine did not remain associated with the membranes but was able to cross them since we found that most of the sitamaquine was located in the cytosol. The data obtained on the parasites confirmed those from the biomimetic monolayer. In addition, since the proportion of anionic lipids is lower in the external outer layer of the plasma membrane than in the inner layer, the quantity of sitamaquine interacting with the membrane would be expected to be low. However, sitamaquine is positively charged and would have more affinity for the inner layer, which is more negatively charged than the outer layer. Therefore, sitamaquine will not stay within the membrane but will cross the bilayer following a concentration gradient and an electrical gradient. When comparing the DA values obtained with miltefosine in a previous study, 10 and those of sitamaquine in the present study (25 Å 2 /molecule, and 3 Å 2 /molecule at 30 mN/m, respectively), it is probable that the presence of sitamaquine in the membrane is very transitory whereas that of miltefosine is more stable because it is inserted, mainly into the lipid rafts, before being internalized by the L. donovani miltefosine transporter (LdMT) protein. 10, 13 In previous work, we found that sitamaquine did not exhibit any affinity for sterols (cholesterol and ergosterol). 7 In order to confirm that the action of sitamaquine was not sterol dependent, in the present study, the sterol content of L. donovani promastigotes was depleted and their sitamaquine susceptibility tested. CH-OX was used to deplete sterols rather than b-methyl-cyclodextrin (MCD) which disrupts lipid rafts and caveolae, 14 -16 because CH-OX has a higher affinity than MCD for condensed lipid microdomains formed by lateral assemblies of sterol and sphingolipids in the cell membrane. It is also known that MCD can extract molecules other than sterols. 17 Sterol depletion using CH-OX did not significantly modify the parasite susceptibility to sitamaquine, confirming the absence of affinity of sitamaquine for sterols described previously. 7 Nevertheless, the possibility that sitamaquine has some affinity for lipid rafts remains, since lipid rafts in Leishmania contain a high proportion of inositolphosphorylceramide (IPC), an anionic lipid with which sitamaquine could interact. 18 It was important to understand how sitamaquine accumulated within the parasite since it is has been observed that sitamaquine both induces extensive alkalinization in L. donovani acidocalcisomes and affects mitochondrial function. 19, 20 Therefore, in the present work, sitamaquine accumulation was measured in L. donovani promastigotes as the net result of entry and possible efflux. The accumulation of sitamaquine was found to be saturable with a plateau reached within the first 30 min of incubation. The large amount of sitamaquine found in cytosol compared with the amount found in membranes shows the bioavailability of the drug within the parasite. Even if sitamaquine enters internal organelles such as acidocalcisomes, its location will probably not be within the membrane but within the soluble compartment of the organelle. Promastigotes were pre-incubated in pH 6.8 PBS with glucose (1 g/L) or without glucose in the presence of 5 mM 2-deoxy-D-glucose and 10 mM azide for 30 min at 268C. Then, all parasites were treated with sitamaquine at a final concentration of 50 mM for 1 h at 268C. Sitamaquine was then assayed according to the protocol described in the Materials and methods section. Cytosol (control) versus cytosol (energy depletion): significant (P,0.01).
